ESC 365 - Effects of pre-existing heart failure with preserved ejection fraction (HFpEF) on the outcomes of patients with COVID-19: a systematic review

HFA Premium Access

Effects of pre-existing heart failure with preserved ejection fraction (HFpEF) on the outcomes of patients with COVID-19: a systematic review

Session: Basic & Translational Late-Breaking Science

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor J. Chen (Gaithersburg, US)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Doctor Jieling Chen

AstraZeneca BioPharmaceuticals, Gaithersburg (United States of America)

1 presentation

0 follower

4 more presentations in this session

Therapeutic effects of urocortin-2 in Heart Failure with preserved Ejection Fraction

Speaker: Miss I. Vasconcelos (Porto, PT)

Clinical and prognostic relevance of cardiac wasting in patients with advanced cancer

Speaker: Doctor A. Lena (Berlin, DE)

The role of miR-146a in the pathophysiology of pulmonary arterial hypertension - therapeutic implications

Speaker: Miss J. Santos Peixoto Gomes (Porto, PT)

Inward Displacement: a novel method for regional left ventricular functional assessment in HFrEF

Speaker: Associate Professor R. Puri (Cleveland, US)

Access the full session

Basic & Translational Late-Breaking Science

Speakers: Doctor J. Chen, Miss I. Vasconcelos, Doctor A. Lena, Miss J. Santos Peixoto Gomes, Associate Professor R. Puri

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources